Table 3.
BMC-Z Deficits in Subjects with CF Relative to Healthy Comparison Group after Adjusting for Covariates
| Covariates | WB–BMC–Z (95%CI) | p–value | R2 | Sp–BMC–Z (95% CI) | p–value | R2 |
|---|---|---|---|---|---|---|
| Females | ||||||
| −0.9 (−1.2- −0.5) | <0.001 | 0.08 | −0.8 (−1.1- −0.4) | <0.001 | 0.07 | |
| HT–Z | −0.2 (−0.5– 0.05) | 0.11 | 0.45 | −0.2 (−0.5– 0.1) | 0.139 | 0.36 |
| HT–Z, LBM–Z | −0.1 (−0.4– 0.15) | 0.40 | 0.56 | −0.2 (−0.5– 0.1) | 0.22 | 0.42 |
| Males | ||||||
| −1.1 (−1.2- −0.7) | <0.001 | 0.14 | −0.9 (−1.3 - −0.6) | <0.001 | 0.11 | |
| HT–Z | −0.4 (−0.7- −0.1) | 0.009 | 0.43 | −0.3 (−0.6–0.04) | 0.09 | 0.41 |
| HT–Z, LBM–Z | −0.2 (−0.5– 0.07) | 0.154 | 0.56 | −0.01 (−0.3–0.3) | 0.922 | 0.50 |